Skull base chordoma

Head and Neck

Volumn 27, Issue 2, 2005, Pages 159-165

  Mendenhall, William M ^a   Mendenhall, Charles M ^b   Lewis, Stephen B ^c   Villaret, Douglas B ^c   Mendenhall, Nancy Price ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b PHOEBE PUTNEY MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cervical spine; Chondrosarcomas; Chordomas; Local control; Proton therapy; Skull base

Indexed keywords

PROTON;

ASPIRATION BIOPSY; CANCER CONTROL; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL SPINE; CHORDOMA; CLINICAL FEATURE; CLIVUS; EPISTAXIS; FISTULA; HEARING LOSS; HUMAN; HYPOPITUITARISM; LIQUORRHEA; MEMORY DISORDER; MENINGITIS; NERVE PARALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; PHOTOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; REVIEW; SKULL BASE TUMOR; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

CHORDOMA; HUMANS; RADIOTHERAPY, ADJUVANT; SKULL BASE NEOPLASMS; SURVIVAL RATE;

EID: 13244272151     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20144     Document Type: Review

References (28)

1. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 2001; 12:1-11.
2. Noël G, Habrand JL, Jauffret E, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol 2003;179:241-248.
3. Scheil S, Brüderlein S, Liehr T, et al. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CHI. Genes Chromosomes Cancer 2001;32:203-211.
4. Riva P, Crosti F, Orzan F, et al. Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer 2003;107:493-497.
5. Kelley MJ, Korczak JF, Sheridan E, Yang X, Goldstein AM, Parry DM. Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33. Am J Hum Genet 2001;69:454-460.
6. Volpe NJ, Liebsch NJ, Munzenrider JE, Lessell S. Neuro-ophthalmologic findings in chordoma and chondrosarcoma of the skull base. Am J Ophthalmol 1993;115:97-104.
7. Fagundes MA, Hug EB, Liebsch NJ, Daly W, Efird J, Munzenrider JE. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse. Int J Radiat Oncol Biol Phys 1995;33:579-584.
8. Haeckel C, Krueger S, Kuester D, et al. Expression of cathepsin K in chordoma. Hum Pathol 2000;31:834-840.
9. Kay PA, Nascimento AG, Unni KK, Salomão DR. Chordoma: cytomorphologic findings in 14 cases diagnosed by fine needle aspiration. Acta Cytol 2003;47:202-208.
10. Gottschalk D, Fehn M, Patt S, Saeger W, Kirchner T, Aigner T. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol 2001;158:1571-1578.
11. Rosenberg AE, Nielsen GP, Keel SB, et al. Chondrosarcoma of the base of the skull. A clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol 1999;23:1370-1378.
12. Juliao SF, Rand N, Schwartz HS. Galectin-3: a biologic marker and diagnostic aid for chordoma. Clin Orthop Rel Res 2002;397:70-75.
13. Naka T, Oda Y, Iwamoto Y, et al. Immunohistochemical analysis of E-cadherin, (α-catenin, β-catenin, γ-catenin, and neural cell adhesion molecule (NCAM) in chordoma. J Clin Pathol 2001;54:945-950.
14. Ishida T, Dorfman HD. Chondroid chordoma versus low-grade chondrosarcoma of the base of the skull: can immunohistochemistry resolve the controversy? J Neuro-Oncol 1994;18:199-206.
15. Naka T, Fukuda T, Chuman H, et al. Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Hum Pathol 1996;27:381-388.
16. American Joint Committee on Cancer. AJCC cancer staging manual, 6th ed. New York: Springer; 2002. p 191-192.
17. Al-Mefty O, Borba LB. Skull base chordomas: a management challenge. J Neurosurg 1997;86:182-189.
18. Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995;36:887-897.
19. Maira G, Pallini R, Anile C, et al. Surgical treatment of clival chordomas: the transsphenoidal approach revisited. J Neurosurg 1996;85:784-792.
20. Thieblemont C, Biron P, Rocher F, et al. Prognostic factors in chordoma: role of postoperative radiotherapy. Eur J Cancer 1995;31A:2255-2259.
21. Fuller DB, Bloom JG. Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 1988;15:331-339.
22. Romero J, Cardenes H, la Torre A, et al. Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 1993;29:27-32.
23. Catton C, O'Sullivan B, Bell R, et al. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 1996;41:67-70.
24. Terahara A, Niemierko A, Goitein M, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999;45:351-358.
25. O'Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE, Rosenberg AE. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer 1994;74:2261-2267.
26. Berson AM, Castro JR, Petti P, et al. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley laboratory experience. Int J Radiat Oncol Biol Phys 1988;15:559-565.
27. Muthukumar N, Kondziolka D, Lundsford LD, Flickinger JC. Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 1998;41:387-392.
28. Fleming GF, Heimann PS, Stephens JK, et al. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 1993;72:714-718.